IXICO PLC (IXI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, IXICO PLC (IXI) has a cash flow conversion efficiency ratio of -0.118x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-1.26 Million ≈ $-153.91 USD) by net assets (GBX10.72 Million ≈ $1.30K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see IXICO PLC (IXI) total market value for the company's overall valuation and market capitalisation.
IXICO PLC - Cash Flow Conversion Efficiency Trend (1993–2025)
This chart illustrates how IXICO PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
IXICO PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IXICO PLC ranked by their cash flow conversion efficiency. Explore IXI operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CARLYLE COMMODIT.CORP.
F:BJ4
|
-0.183x |
|
Manolete Partners PLC
LSE:MANO
|
0.081x |
|
Zinc Media Group
LSE:ZIN
|
0.066x |
|
Premier Health of America Inc
V:PHA
|
-0.010x |
|
Ground Rents Income Fund PLC
LSE:GRIO
|
0.029x |
|
Conygar Investment Co PLC
LSE:CIC
|
0.290x |
|
Gladstone Land Corporation 6.00% Series C Cumulative Redeemable Preferred Stock
NASDAQ:LANDP
|
0.005x |
|
QUICKBIT EU AB O.N.
F:QBT
|
-0.500x |
Annual Cash Flow Conversion Efficiency for IXICO PLC (1993–2025)
The table below shows the annual cash flow conversion efficiency of IXICO PLC from 1993 to 2025. View today's stock price for IXICO PLC for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | GBX11.74 Million ≈ $1.43K |
GBX-883.00K ≈ $-107.44 |
-0.075x | +58.89% |
| 2024-09-30 | GBX9.46 Million ≈ $1.15K |
GBX-1.73 Million ≈ $-210.73 |
-0.183x | -792.77% |
| 2023-09-30 | GBX11.43 Million ≈ $1.39K |
GBX302.00K ≈ $36.74 |
0.026x | -76.92% |
| 2022-09-30 | GBX12.49 Million ≈ $1.52K |
GBX1.43 Million ≈ $173.99 |
0.114x | +114.00% |
| 2021-09-30 | GBX11.48 Million ≈ $1.40K |
GBX614.00K ≈ $74.71 |
0.053x | -74.82% |
| 2020-09-30 | GBX9.12 Million ≈ $1.11K |
GBX1.94 Million ≈ $235.68 |
0.212x | +1393.93% |
| 2019-09-30 | GBX7.92 Million ≈ $963.51 |
GBX-130.00K ≈ $-15.82 |
-0.016x | -133.88% |
| 2018-09-30 | GBX7.33 Million ≈ $891.36 |
GBX355.00K ≈ $43.19 |
0.048x | +120.23% |
| 2017-09-30 | GBX2.69 Million ≈ $327.17 |
GBX-644.00K ≈ $-78.36 |
-0.239x | +36.26% |
| 2016-09-30 | GBX4.08 Million ≈ $497.03 |
GBX-1.53 Million ≈ $-186.77 |
-0.376x | +22.65% |
| 2015-09-30 | GBX2.71 Million ≈ $329.61 |
GBX-1.32 Million ≈ $-160.12 |
-0.486x | -8.58% |
| 2014-09-30 | GBX3.81 Million ≈ $463.81 |
GBX-1.71 Million ≈ $-207.51 |
-0.447x | +63.80% |
| 2013-09-30 | GBX3.59 Million ≈ $436.92 |
GBX-4.44 Million ≈ $-539.98 |
-1.236x | -15.05% |
| 2012-09-30 | GBX8.37 Million ≈ $1.02K |
GBX-9.00 Million ≈ $-1.09K |
-1.074x | -166.95% |
| 2011-09-30 | GBX15.96 Million ≈ $1.94K |
GBX-6.42 Million ≈ $-781.62 |
-0.402x | -112.69% |
| 2010-09-30 | GBX23.48 Million ≈ $2.86K |
GBX-4.44 Million ≈ $-540.46 |
-0.189x | +82.54% |
| 2009-09-30 | GBX3.14 Million ≈ $381.68 |
GBX-3.40 Million ≈ $-413.68 |
-1.084x | -200.60% |
| 2008-09-30 | GBX7.16 Million ≈ $871.29 |
GBX-2.58 Million ≈ $-314.15 |
-0.361x | +81.49% |
| 2007-09-30 | GBX2.80 Million ≈ $340.80 |
GBX-5.46 Million ≈ $-663.84 |
-1.948x | -115.77% |
| 2006-08-31 | GBX6.48 Million ≈ $788.31 |
GBX-5.85 Million ≈ $-711.65 |
-0.903x | -181.11% |
| 2005-08-31 | GBX11.81 Million ≈ $1.44K |
GBX-3.79 Million ≈ $-461.62 |
-0.321x | +70.85% |
| 2004-08-31 | GBX5.29 Million ≈ $643.88 |
GBX-5.83 Million ≈ $-709.46 |
-1.102x | -56.48% |
| 2003-08-31 | GBX5.10 Million ≈ $620.16 |
GBX-3.59 Million ≈ $-436.68 |
-0.704x | -55.28% |
| 2002-08-31 | GBX10.29 Million ≈ $1.25K |
GBX-4.66 Million ≈ $-567.47 |
-0.453x | -126.95% |
| 2001-08-31 | GBX13.09 Million ≈ $1.59K |
GBX-2.62 Million ≈ $-318.29 |
-0.200x | +56.81% |
| 2000-08-31 | GBX4.76 Million ≈ $579.15 |
GBX-2.20 Million ≈ $-267.92 |
-0.463x | +47.78% |
| 1999-08-31 | GBX2.06 Million ≈ $250.64 |
GBX-1.82 Million ≈ $-222.05 |
-0.886x | +33.54% |
| 1998-08-31 | GBX2.95 Million ≈ $359.42 |
GBX-3.94 Million ≈ $-479.14 |
-1.333x | -244.33% |
| 1997-08-31 | GBX6.48 Million ≈ $788.19 |
GBX-2.51 Million ≈ $-305.15 |
-0.387x | -430.08% |
| 1996-08-31 | GBX9.54 Million ≈ $1.16K |
GBX-697.00K ≈ $-84.80 |
-0.073x | +45.55% |
| 1995-08-31 | GBX-2.52 Million ≈ $-306.61 |
GBX338.00K ≈ $41.12 |
-0.134x | -118.43% |
| 1994-08-31 | GBX-2.71 Million ≈ $-329.61 |
GBX-1.97 Million ≈ $-239.81 |
0.728x | -51.56% |
| 1993-08-31 | GBX-512.00K ≈ $-62.30 |
GBX-769.00K ≈ $-93.57 |
1.502x | -- |
About IXICO PLC
IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imag… Read more